drugset / Trial / NCT00901654
ACE527 Safety and Immunogenicity Study
Phase 1
Completed
36 enrolled
TD Vaccines A/S
Johns Hopkins University · collabPierrel Research USA, Inc. · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to evaluate the safety and immune response to ACE527.
Timeline
- Start
- 2009-06
- Primary completion
- 2009-11
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ACE527 | Vaccine | 9e+09 unknown | Oral |
| Subject | ACE527 | Vaccine | 9e+10 unknown | Oral |
Indications
No indication recorded.